Long COVID is often described as a prolonged period of illness following infection with SARS-CoV-2, but what is the official definition, what are the symptoms and who is most at risk?
In this interview, we speak with Prof. Nisreen Alwan (University of Southampton, Southampton UK), a Professor in Public Health with personal experience of long COVID, and someone who has spent the last two years at the forefront of the pandemic as an advocate raising awareness of the condition.
- What is the NICE definition of long COVID and what are its symptoms? (0:23)
- How does long COVID differ from other post-viral infection syndromes? (1:17)
- What do we know about the trajectory of long COVID symptoms? (2:02)
- Who is most at risk of long COVID? (2:45)
Disclosures: Prof. Nisreen Alwan has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Gina Furnival.
Share this Video
Related Videos In COVID-19
Ruth Link-Gelles, IDWeek 2022: Efficacy of COVID-19 vaccination in paediatric populations
In this touchINFECTIOUS DISEASES interview, we met with Dr Ruth Link-Gelles (Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA) to discuss the incidence of COVID-19 in children, vaccine effectiveness against infection and disease severity, and the current status of paediatric COVID-19 vaccines in the United States. Interviews available in this series: Real world […]
Ruth Link-Gelles, IDWeek 2022: Real world effectiveness of paediatric COVID-19 vaccination
COVID-19 typically causes less severe illness and fewer deaths in children and adolescents compared to adults. Nonetheless, children and adolescents remain susceptible to COVID-19 infection and can transmit to others. In this touchINFECTIOUS DISEASES interview, we met with Dr Ruth Link-Gelles (Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA) to discuss real-world findings of […]
Christoph Boesecke: Impact of COVID-19 on the treatment of patients living with HIV
Key clinical highlights in HIV infection are discussed in this interview with touchINFECTIOUS DISEASES Editorial Board member, Dr Christoph Boesecke (Infectious Diseases Specialist, Senior Lecturer, University of Bonn, Bonn, Germany). He discusses the delays caused by the COVID-19 pandemic and the impact that has had on the treatment of patients living with HIV. He also […]
Journal articles and more to your inbox
Get the latest clinical insights from touchINFECTIOUS DISEASESSign me up!